Skip to main content
Mohammed Kashani-Sabet, MD, Dermatology, San Francisco, CA

Mohammed Kashani-Sabet MD


Physician

Join to View Full Profile
  • 2340 Clay StSan Francisco, CA 94115

  • Phone+1 415-600-3800

  • Fax+1 415-600-3865

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 1 invite waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Mohammed Kashani-Sabet, MD is a board certified dermatologist in San Francisco, California. He is currently licensed to practice medicine in California.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Dermatology, 1992 - 1995
  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1991 - 1992
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - 2026
  • Dermatology
    American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Press Mentions

  • Sutter Health Researchers Discover Promising Drug Combinations to Combat Immunotherapy-Resistant Melanoma
    Sutter Health Researchers Discover Promising Drug Combinations to Combat Immunotherapy-Resistant MelanomaSeptember 16th, 2025
  • Promising Drug Combinations for Immunotherapy-Resistant Melanoma May Also Help Reactivate Immune System
    Promising Drug Combinations for Immunotherapy-Resistant Melanoma May Also Help Reactivate Immune SystemSeptember 16th, 2025
  • HMN 2025: How Promising Outcomes of Niraparib Are Seem in Sufferers with Superior Melanoma
    HMN 2025: How Promising Outcomes of Niraparib Are Seem in Sufferers with Superior MelanomaMay 24th, 2025
  • Join now to see all